Icarus Medical, a Virginia-based medtech company developing advanced orthopedic bracing solutions, has raised $7.2 million in funding, exceeding its original $5 million target. The round attracted support from investors including Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors.
Expanding Commercial Growth
The funding will support U.S. commercialization efforts, product development, manufacturing expansion, clinical validation programs, and team growth as the company increases its national footprint.
“This financing represents a major milestone for Icarus Medical and validates both the clinical impact of our technology and the strength of the team we have built,” said Dave Johnson, Founder and CEO of Icarus Medical.
Advancing Orthopedic Bracing
Founded in Charlottesville, Icarus Medical develops orthopedic devices that combine biomechanics, additive manufacturing, and patient-centered design. The company’s portfolio includes the Ascender Knee Brace for osteoarthritis, alongside solutions for post-operative recovery, neurological conditions, and mobility challenges.
Growing Industry Recognition
Over the past year, Icarus Medical was named to the Inc. 5000 list after achieving 1,283% growth over three years. The company also received the 2026 CBIC Startup of the Year Award.
“Through engagement with our clinicians, we quickly validated that conviction and received strong feedback regarding both the significant unmet need and the value of Icarus’ innovative bracing technology,” said Ben Spektor, Director of Venture Investments at OSF Ventures.
Scaling Manufacturing
The company continues to design and manufacture products in Charlottesville while expanding production capabilities and creating new jobs to support future growth.